Ocular myasthenia gravis: Treatment successes and failures in patients with long-term follow-up

Journal of Neurology

Volumn 256, Issue 8, 2009, Pages 1314-1320

  Kupersmith, Mark J ^a,b,c  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Diplopia; Ocular myasthenia gravis; Prednisone; Ptosis

Indexed keywords

AZATHIOPRINE; CALCIUM; FAMOTIDINE; ISONIAZID; MYCOPHENOLIC ACID; NIZATIDINE; PREDNISONE; PYRIDOSTIGMINE; PYRIDOXINE; RANITIDINE;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DATA BASE; DIPLOPIA; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NEUROOPHTHALMOLOGY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PTOSIS; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DIPLOPIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; OCULOMOTOR MUSCLES; PREDNISONE; RETROSPECTIVE STUDIES; TIME; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68349142911     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5120-8     Document Type: Article

References (29)

1. N Schlezinger W Fairfax 1959 Evaluation of ocular signs and symptoms in myasthenia gravis Arch Ophthalmol 62 985 990
2. C Bever A Aquino A Penn R Lovelace L Rowland 1983 Prognosis of ocular myasthenia Ann Neurol 14 516 519 10.1002/ana.410140504
3. Grob D (1999) Natural history of myasthenia gravis. In: Engel AG (ed) Myasthenia gravis and myasthenic disorders. Oxford University Press, Oxford, pp 135-136
4. MJ Kupersmith R Latkany 2003 Development of generalized disease at two years in patients with ocular myasthenia gravis Arch Neurol 60 243 248 10.1001/archneur.60.2.243 (Pubitemid 36193969)
5. MJ Kupersmith M Moster S Bhuiyan F Warren H Weinberg 1996 Beneficial effects of corticosteroids on ocular myasthenia gravis Arch Neurol 53 802 804
6. N Monsul H Patwa A Knorr R Lesser J Goldstein 2004 The effect of prednisone on the progression from ocular to generalized myasthenia gravis J Neurol Sci 217 131 134 10.1016/j.jns.2003.08.017 (Pubitemid 38056545)
7. MJ Kupersmith GS Ying 2005 Ocular motor dysfunction in ocular myasthenia gravis: effects of treatment Br J Ophthalmol 89 1330 1334 10.1136/bjo.2004. 063404 (Pubitemid 41638875)
8. R Pascuzzi H Coslett T Johns 1984 Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients Ann Neurol 15 291 298 10.1002/ana.410150316 (Pubitemid 14164748)
9. J Caldwell D Furst 1991 The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis Semin Arthritis Rheum 21 1 11 10.1016/0049-0172(91)90051-Z
10. H Hatz K Helmke 1992 Polymyalgia rheumatica and giant cell arthritis; diagnosis and side effects of low-dose long-term glucocorticoid therapy Z Rheumatol 51 213 221
11. RF Spiera HJ Mitnick MJ Kupersmith M Richmond H Spiera MGE Peterson SA Paget 2001 A prospective double-blind randomized placebo-controlled trial of methotrexate in the treatment of giant cell arteritis (GCA) Clin Exp Rheumatol 19 495 501
12. M Benatar H Kaminski 2007 Evidence report: the medical treatment of ocular myasthenia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 68 2144 2149 10.1212/01.wnl.0000263481.14289.90 (Pubitemid 46912135)
13. M Gilbert A De Sousa P Savino 2007 Ocular myasthenia gravis treatment: the case against prednisone and thymectomy Arch Neurol 64 1790 1792 10.1001/archneur.64.12.1790 (Pubitemid 350254946)
14. P Chavis D Stickler A Walker 2007 Immunosuppressive or surgical treatment of ocular myasthenia gravis Arch Neurol 64 1792 1794 10.1001/archneur.64.12. 1792 (Pubitemid 350254947)
15. E Roach 2007 Treating ocular myasthenia gravis with inadequate evidence Arch Neurol 64 1794 1795 10.1001/archneur.64.12.1794 (Pubitemid 350254948)
16. H Kaminski R Daroff 2000 Treatment of ocular myasthenia. Steroids only when compelled Arch Neurol 57 752 753 10.1001/archneur.57.5.752
17. M Vargas F Warren MJ Kupersmith 1993 Exotropia as a sign of myasthenia gravis in dysthyroid ophthalmopathy Br J Ophthalmol 77 822 823 10.1136/bjo.77.12.822
18. J Odel J Winterkorn M Behrens 1991 The sleep test for myasthenia gravis. A safe alternative to Tensilon J Clin Neuroophthalmol 11 288 292
19. H Oosterhuis 1982 The ocular signs and symptoms of myasthenia gravis Doc Ophthalmol 52 363 378 10.1007/BF01675867
20. Kupersmith MJ, Weinberg H, Frohman L et al. (1988) Ocular myasthenia gravis: diagnosis and treatment. In: Smith J, Katz R (eds) Neuro-ophthalmology enters the Nineties. Dutton, Hialeah, pp 173-182
21. Fisher L, van Belle G (1993) Biostatistics. A methodology for the health sciences. Wiley, New York
22. N Sommer B Sigg A Melms M Weller K Schepelmann V Herzau J Dichgans 1997 Ocular myasthenia gravis: response to long term immunosuppressive treatment J Neurol Neurosurg Psychiatry 62 156 162 10.1136/jnnp.62.2.156
23. V Chaudhry D Cornblath J Griffin R O'Brien D Drachman 2001 Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases Neurology 56 94 96
24. M Meriggioli E Ciafaloni K Al-Hayk J Rowin B Tucker-Lipscomb J Massey D Sanders 2003 Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability Neurology 61 1438 1440 (Pubitemid 37463389)
25. J Chan 2008 Mycophenolate mofetil for ocular myasthenia gravis J Neurol 255 510 513 10.1007/s00415-008-0718-9
26. M Schumm H Wietholter A Fateh-Moghadam J Dichgans 1985 Thymectomy in myasthenia with pure ocular symptoms J Neurol Neurosurg Psychiatry 48 332 337 10.1136/jnnp.48.4.332 (Pubitemid 15109111)
27. H Nakamura Y Taniguchi Y Suzuki Y Tanaka K Ishiguro M Fukudo H Hara T Mori 1996 Delayed remission after thymectomy for myasthenia gravis of the purely ocular type J Thorac Cardiovasc Surg 11 371 375 10.1016/S0022-5223(96)70264-7
28. P Roberts F Venuto E Rendina T De Giacomo G Coloni D Follette D Richman J Benfield 2001 Thymectomy in the treatment of ocular myasthenia gravis J Thorac Cardiovasc Surg 122 562 568
29. S Endo T Yamaguchi N Saito S Otani T Hasegawa Y Sato Y Sohara 2004 Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis Ann Thorac Surg 77 1745 1750 10.1016/j.athoracsur.2003.10.039 (Pubitemid 38530017)